HK Stock MarketDetailed Quotes

CANSINOBIO (06185)

Watchlist
  • 28.180
  • +1.820+6.90%
15min DelayNot Open Sep 21 16:08 CST
6.96BMarket Cap149.10P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CANSINOBIO (06185) Revenue Breakdown Overview

By Business/Source

Currency:CNY
2026/H1
Stock NameRevenueRatio
疫苗及相关产品–疫苗393.5M71.98%
疫苗及相关产品–中间品98.82M18.08%
技术转移及CDMO53.34M9.76%
许可费收入1M0.18%

By Product

Currency:CNY
2026/H1
Stock NameRevenueRatio
疫苗及相关产品–疫苗393.5M71.98%
疫苗及相关产品–中间品98.82M18.08%
技术转移及CDMO53.34M9.76%
许可费收入1M0.18%

By Country/Region

Currency:CNY
2026/H1
Stock NameRevenueRatio
China394.5M72.17%
Overseas152.16M27.83%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +7.28%
Sample Name
Sample Code
 +5.73%
Sample Name
Sample Code
 +2.60%
4
SINO OIL & GAS
00702
0.00%
5
SINOPEC CORP
00386
-1.27%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +33.04%
Sample Name
Sample Code
 +16.29%
Sample Name
Sample Code
 +13.40%
4
Capitalonline Data Service
300846
+12.44%
5
Lotus Holdings
600186
+10.33%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -